Related Experiment Video
Updated: Oct 20, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan
Jui-Wen Peng1, Oswald Ndi Nfor2, Chien-Chang Ho3,4
1Institute of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
Insights
The GG genotype of the CYP2C9 rs2860905 variant increases ischemic stroke risk in Taiwanese adults, especially when combined with atrial fibrillation. This genetic factor is crucial for understanding stroke in Taiwan.
Area of Science:
- Cardiovascular Genetics
- Neurology
- Pharmacogenomics
Background:
- Ischemic stroke is a leading cause of disability, with atrial fibrillation as a significant risk factor.
- Limited evidence exists on the interplay between atrial fibrillation, genetic variants, and ischemic stroke risk.
Purpose of the Study:
- To investigate the association between the CYP2C9 rs2860905 variant, atrial fibrillation, and ischemic stroke risk in the Taiwan Biobank population.
- To assess the role of genetic factors in ischemic stroke among Taiwanese adults.
Main Methods:
- Logistic regression analysis was employed to analyze data from 17,726 participants in the Taiwan Biobank.
- Odds ratios (OR) and 95% confidence intervals (CI) were calculated to determine the risk associated with atrial fibrillation and the rs2860905 variant.
- Genotype-stratified analysis was performed to examine gene-environment interactions.
Main Results:
- Atrial fibrillation showed a significant positive association with ischemic stroke (OR=3.70; 95% CI, 2.21-6.20).
- The rs2860905 variant itself was not directly associated with ischemic stroke risk (OR=1.00; 95% CI, 0.82-1.22 for GA/AA vs. GG genotype).
- Individuals with the GG genotype and atrial fibrillation had a substantially higher risk of ischemic stroke (OR=4.68; 95% CI, 2.70-8.09) compared to those without atrial fibrillation.
Conclusions:
- The GG genotype of CYP2C9 rs2860905 significantly enhances ischemic stroke risk in Taiwanese adults, particularly when co-occurring with atrial fibrillation.
- This genotype-specific risk warrants consideration in clinical and research settings for stroke prevention and management in Taiwan.
- Understanding genetic predispositions like the CYP2C9 rs2860905 variant is vital for personalized medicine approaches to cardiovascular diseases.
Purpose:
Ischemic stroke accounts for approximately 85% of all strokes. Risk factors include atrial fibrillation, metabolic disorders, and genetic and lifestyle factors. There is limited evidence to support the association between atrial fibrillation and the risk of ischemic stroke based on genetic variants. We assessed the relationship between ischemic stroke and atrial fibrillation among participants in Taiwan Biobank (TWB) based on the rs2860905 variant of the cytochrome P450 Family 2 Subfamily C Member 9 (CYP2C9) gene.
Materials And Methods:
Using logistic regression analysis, we estimated the odds ratios (OR) and 95% confidence intervals (CI) for ischemic stroke among 17,726 biobank adults recruited from 2008 through 2015.
Results:
Of the eligible participants (n = 17,726), 906 were identified with ischemic stroke. Atrial fibrillation was positively associated with ischemic stroke (OR=3.70; 95% CI, 2.21-6.20), whereas the rs2860905 variant was not. The OR for ischemic stroke among those with GA/AA genotype was 1.00 (95% CI, 0.82-1.22) compared to those with the GG genotype. Based on the genotype-stratified analysis, the OR for ischemic stroke was 4.68 (95% CI, 2.70-8.09) among individuals with GG genotype who had atrial fibrillation compared to those who did not.
Conclusion:
These results demonstrate that the GG genotype of the CYP2C9 rs2860905 variant appears to enhance the risk of ischemic stroke among adults in Taiwan. It could be essential to factor this genotype-specific contributor to ischemic stroke into clinical and experimental investigations of the disease in Taiwan.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Acute Coronary Syndrome III: Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

